Showing results (1-10 of 301) with videos related to
Sort By:
Pageof 31
Methods in Molecular Medicine|June 22, 2005
Detecting mismatch repair defects in myelomaMark Velangi, Elizabeth Matheson, Andrew Hall, et al.Leukemia Research|September 22, 2009
Alternative splicing of hMLH1 in childhood acute lymphoblastic leukaemia and characterisation of the variably expressed Delta9/10 isoform as a dominant negative speciesAmy Peasland, Elizabeth Matheson, Andy Hall, et al.Hematology Reports|December 21, 2011
Two cases of aspergillus endocarditis in non neutropenic children on chemotherapy for acute lymphoblastic leukaemiaEmmanouil Nikolousis, Mark VelangiGenes, Chromosomes & Cancer|November 11, 2011
Casitas B lymphoma mutations in childhood acute lymphoblastic leukemiaLindsay Nicholson, Thomas Knight, Elizabeth Matheson, et al.Journal of Pediatric Surgery|February 14, 2012
Introduction of sodium pentosan polysulfate and avoidance of urethral catheterisation: improved outcomes in children with haemorrhagic cystitis post stem cell transplant/chemotherapyGillian Duthie, Lisa Whyte, Harish Chandran, et al.British Journal of Haematology|February 3, 2005
Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based surveyT C M Morris, Mark Velangi, Graham Jackson, et al.BMJ Open|May 25, 2019
British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphomaNadia Amin, Sally Kinsey, Richard Feltbower, et al.The Lancet. Infectious Diseases|March 23, 2007
Micronutrient supplements for children after dewormingAndrew HallBlood|September 26, 2014
Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibitionJulie Irving, Elizabeth Matheson, Lynne Minto, et al.BMJ Open|July 3, 2026
Single-round modified Delphi consensus to optimise the care of patients with sickle cell disease across multidisciplinary teams within the NHSWale Atoyebi, Mark Velangi, Kofi A Anie, et al.Pageof 31